RISING PHARMA HOLDINGS INC
RISING PHARMA HOLDINGS INC (United States) holds 2 active US FDA Type II Drug Master Files and has DMF or CEP filings on record for 2 active ingredients. 32 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “RISING PHARMA HOLDINGS INC: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/rising-pharma-holdings-inc
Overview
RISING PHARMA HOLDINGS INC is an active pharmaceutical ingredient (API) supplier with 2 active FDA Type II Drug Master Files, covering COLESTIPOL HYDROCHLORIDE (POVIDONE PREMIX); METAXALONE.
Core services & business areas
Active ingredients with DMF or CEP filings
Substances for which RISING PHARMA HOLDINGS INC holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
RISING PHARMA HOLDINGS INC holds 2 active (2 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- COLESTIPOL HYDROCHLORIDE (POVIDONE PREMIX)Active2019-02-21
- METAXALONEActive2000-10-11
FDA compliance signals
32 FDA enforcement records linked to this company.
- 4832022-04-08
Investigations of discrepancies, failures
- 4832022-04-08
Absence of Written Procedures
- 4832022-04-08
Procedures for sterile drug products
- warning_letter2019-01-04
FDA Warning Letter (drug product)
- 4832017-04-26
Procedures not in writing, fully followed
- 4832017-04-26
Equipment Design, Size and Location
- 4832017-04-26
Validation lacking for sterile drug products
- 4832014-06-06
Sanitation--buildings not clean, free of infestation
- 4832010-09-17
Written record of investigation incomplete
- 4832010-09-17
Quality control unit review of records
- 4832010-09-17
Failing drug products not rejected
- 4832010-09-17
Components withheld from use pending release
- 4832010-09-17
SOPs not followed / documented
- 4832010-09-17
Procedures To Be in Writing
- 4832010-09-17
Expiration date lacking
- 4832010-09-17
Rejecting When Specifications Not Met
- 4832010-09-17
Manufacturing Instructions and Specifications
- 4832010-09-17
Investigations of discrepancies, failures
- 4832009-06-30
Validation lacking for sterile drug products
- 4832009-06-30
Cleaning / Sanitizing / Maintenance
- 4832009-06-30
Calibration/Inspection/Checking not done
- 4832009-06-30
Adverse Drug Experience
- 4832009-06-30
Cleaning SOPs/instructions
- 4832009-06-30
Items to cover on annual reviews
- 4832009-06-30
Investigations of discrepancies, failures
- 4832009-06-30
Investigations made into any unexplained discrepancy
- 4832009-06-30
Reprocessing procedures not written or followed
- 4832009-06-30
Approval and review of procedures
- 4832009-06-30
Procedures not in writing, fully followed
- 4832009-06-30
Testing Each Component for Conformity with Specs
- 4832009-06-30
Rejecting When Specifications Not Met
- 4832009-06-30
Scientifically sound laboratory controls
Is this RISING PHARMA HOLDINGS INC?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.